Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
44 questions in 13 reviews · Breast Cancer
current versionsNo studies 44 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Shared decision‐making (all components) vs control Satisfaction with the decision‐making process · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Some components of shared decision‐making, including clarification of values and preferences, vs control Adherence to the chosen option · women aged 38 to 71 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Some components of shared decision‐making, including clarification of values and preferences, vs control Choice of an option aligned with each woman’s values and preferences · women aged 38 to 71 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Some components of shared decision‐making, including clarification of values and preferences, vs control Woman's involvement · women aged 38 to 71 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Studies focused only on enhanced communication, without clarification of values and preferences, vs control Satisfaction with the decision‐making process · women aged 40 to 75 years old at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Studies focused only on enhanced communication, without clarification of values and preferences, vs control Adherence to the chosen option · women aged 40 to 75 years old at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Studies focused only on enhanced communication, without clarification of values and preferences, vs control Choice of an option aligned with each woman’s values and preferences · women aged 40 to 75 years old at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Shared decision‐making (all components) vs control Confidence in the decision made · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Studies focused only on enhanced communication, without clarification of values and preferences, vs control Woman's involvement · women aged 40 to 75 years old at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Shared decision‐making (all components) vs control Adherence to the chosen option · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Shared decision‐making (all components) vs control Choice of an option aligned with each woman’s values and preferences · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Shared decision‐making (all components) vs control Woman's involvement · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Shared decision‐making (all components) vs control Mental health outcomes · women aged 40 to 75 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Some components of shared decision‐making, including clarification of values and preferences, vs control Satisfaction with the decision‐making process · women aged 38 to 71 years at average to moderate risk of breast cancer Shared decision‐making for supporting women’s decisions about breast cancer screening (2024) · Cochrane | no estimate extracted | NR | No studies |
Mammography in combination with breast ultrasonography vs mammography alone Outcomes after 1‐ to 2‐year · s of women with dense and non‐dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Mammography in combination with breast ultrasonography vs mammography alone Outcomes after 1‐ to 2‐year · breast cancer screening in women at average risk with dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Mammography in combination with breast ultrasonography vs mammography alone Breast cancer mortality · s of women with dense and non‐dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Mammography in combination with breast ultrasonography vs mammography alone Outcomes after 1‐ to 2‐year · breast cancer screening (non‐dense breasts) Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Mammography in combination with breast ultrasonography vs mammography alone All‐cause mortality · s of women with dense and non‐dense breasts Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Platinum‐containing chemotherapy vs chemotherapy without platinum Quality of life · early triple‐negative breast cancer Platinum‐based chemotherapy for early triple‐negative breast cancer (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR General health‐related quality of life · women with advanced breast cancer Specialist breast care nurses for support of women with breast cancer (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Anxiety and depression · women with advanced breast cancer Specialist breast care nurses for support of women with breast cancer (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Service provision (patient perspective) · women with advanced breast cancer Specialist breast care nurses for support of women with breast cancer (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Service provision‐patient perspective · women with primary breast cancer Specialist breast care nurses for support of women with breast cancer (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Overall survival · overweight and obese breast cancer survivors Body weight management in overweight and obese breast cancer survivors (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Breast cancer recurrence · overweight and obese breast cancer survivors Body weight management in overweight and obese breast cancer survivors (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Disease‐free survival ‐ not reported · overweight and obese breast cancer survivors Body weight management in overweight and obese breast cancer survivors (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events · overweight and obese breast cancer survivors Body weight management in overweight and obese breast cancer survivors (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Change in quality of life ‐ overall scales · overweight and obese breast cancer survivors Body weight management in overweight and obese breast cancer survivors (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Disease‐free survival · overweight and obese breast cancer survivors Body weight management in overweight and obese breast cancer survivors (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Overall survival · overweight and obese breast cancer survivors Body weight management in overweight and obese breast cancer survivors (2020) · Cochrane | no estimate extracted | NR | No studies |
Indocyanine Green Angiography (ICGA) vs clinical evaluation Dehiscence ‐ not reported · women undergoing immediate breast reconstruction following mastectomy Indocyanine green angiography for preventing postoperative mastectomy skin flap necrosis in immediate breast… (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Nephrotoxicity (safety population) · women with metastatic triple‐negative breast cancer (mTNBC) Platinum‐containing regimens for triple‐negative metastatic breast cancer (2020) · Cochrane | no estimate extracted | NR | No studies |
MBSR vs usual care Overall survival · women diagnosed with breast cancer Mindfulness‐based stress reduction for women diagnosed with breast cancer (2019) · Cochrane | no estimate extracted | NR | No studies |
MBSR vs usual care Adverse events · women diagnosed with breast cancer Mindfulness‐based stress reduction for women diagnosed with breast cancer (2019) · Cochrane | no estimate extracted | NR | No studies |
Taxane followed by anthracyclines vs anthracyclines followed by taxane Quality of life · neoadjuvant therapy for early breast cancer Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer (2019) · Cochrane | no estimate extracted | NR | No studies |
Taxane followed by anthracyclines vs anthracyclines followed by taxane Overall survival · adjuvant therapy for early breast cancer Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer (2019) · Cochrane | no estimate extracted | NR | No studies |
Taxane followed by anthracyclines vs anthracyclines followed by taxane Disease‐free survival · adjuvant therapy for early breast cancer Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer (2019) · Cochrane | no estimate extracted | NR | No studies |
Breast surgery plus systemic treatment vs systemic treatment Quality of life · metastatic breast cancer Breast surgery for metastatic breast cancer (2018) · Cochrane | no estimate extracted | NR | No studies |
Breast surgery plus systemic treatment vs systemic treatment Breast cancer‐specific survival · metastatic breast cancer Breast surgery for metastatic breast cancer (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR *CI: Confidence interval · breast cancer survivors Home‐based multidimensional survivorship programmes for breast cancer survivors (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Emotional distress · women with breast cancer Online support groups for women with breast cancer (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Uncertainty · women with breast cancer Online support groups for women with breast cancer (2017) · Cochrane | no estimate extracted | NR | No studies |
Hypofractionated radiation therapy vs conventionally fractionated radiation therapy Mastectomy rate ‐ not measured · women treated with breast conserving therapy for early breast cancer Hypofractionated radiation therapy for early breast cancer (2016) · Cochrane | no estimate extracted | NR | No studies |